#Research
Cheap Heartburn remedy might provide a cheap alternative against the Wuhan Virus
Most news headlines on Wuhan Virus treatment have focused on remdesivir, chloroquine and hydroxychloroquine. However, such early coverage has drawn premature popularity for those drugs. For instance, Donald Trump has promoted the use of chloroquine before the completion of clinical trials, and some patients suffered from side effects after taking chloroquine without medical supervision (https://www.businessinsider.com/trump-touts-chloroquine-for-covid-19-but-dismisses-risks-2020-4). Moreover, drug candidates tend to have higher demand from the public and hospitals after gaining public popularity. As a result, there is insufficient stockpile left for clinical trials and treatments for other diseases.
In contrast to the aforementioned drug candidates, clinical trails are quietly conducted for a cheap heartburn remedy called famotidine. Researches on famotidine have been kept in low profile to avoid drawing premature attention and reserving sufficient stockpile for clinical trials.
Infectious disease doctor named Michael Callahan and doctors from Wuhan first noticed the potential clinical effect of famotidine. Callahan and colleagues noticed poor peasants seem to have a higher survival rate. After further investigation of patient's records, Callahan and colleagues realised the higher survival rate coincides with stomach illness treatment by famotidine, a cheap medicine taken by poorer people.
The initial observation of famotidine was reported to Robert Malone, a chief medical officer of Florida-based Alchem Laboratories. Malone and computational chemist Joshua Pottel later computationally predicted that famotidine can target a protein the Wuhan Virus, which is a sign that famotidine may prevent Wuhan Virus from replicating. Adding to that, later observations have seen infected hospital staffs showing improved recovery after taking famotidine.
While famotidine may provide a low-cost and safe alternative against the Wuhan Virus, it is still too early to assign famotidine as a routine treatment against the Wuhan Virus. The potential of famotidine requires further examinations with an ongoing clinical trial involving 1174 participants.
Source: ScienceMag
#Coronavirus #WuhanVirus #Trump #Treatment #famotidine
Cheap Heartburn remedy might provide a cheap alternative against the Wuhan Virus
Most news headlines on Wuhan Virus treatment have focused on remdesivir, chloroquine and hydroxychloroquine. However, such early coverage has drawn premature popularity for those drugs. For instance, Donald Trump has promoted the use of chloroquine before the completion of clinical trials, and some patients suffered from side effects after taking chloroquine without medical supervision (https://www.businessinsider.com/trump-touts-chloroquine-for-covid-19-but-dismisses-risks-2020-4). Moreover, drug candidates tend to have higher demand from the public and hospitals after gaining public popularity. As a result, there is insufficient stockpile left for clinical trials and treatments for other diseases.
In contrast to the aforementioned drug candidates, clinical trails are quietly conducted for a cheap heartburn remedy called famotidine. Researches on famotidine have been kept in low profile to avoid drawing premature attention and reserving sufficient stockpile for clinical trials.
Infectious disease doctor named Michael Callahan and doctors from Wuhan first noticed the potential clinical effect of famotidine. Callahan and colleagues noticed poor peasants seem to have a higher survival rate. After further investigation of patient's records, Callahan and colleagues realised the higher survival rate coincides with stomach illness treatment by famotidine, a cheap medicine taken by poorer people.
The initial observation of famotidine was reported to Robert Malone, a chief medical officer of Florida-based Alchem Laboratories. Malone and computational chemist Joshua Pottel later computationally predicted that famotidine can target a protein the Wuhan Virus, which is a sign that famotidine may prevent Wuhan Virus from replicating. Adding to that, later observations have seen infected hospital staffs showing improved recovery after taking famotidine.
While famotidine may provide a low-cost and safe alternative against the Wuhan Virus, it is still too early to assign famotidine as a routine treatment against the Wuhan Virus. The potential of famotidine requires further examinations with an ongoing clinical trial involving 1174 participants.
Source: ScienceMag
#Coronavirus #WuhanVirus #Trump #Treatment #famotidine
Business Insider
Trump is touting experimental drugs for COVID-19, saying they're 'not going to hurt' people. But the drugs have severe side effects…
"It can help them, but it's not going to hurt them," President Donald Trump argued Sunday. But as with most drugs, there are side effects.